Effect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients With Breast Cancer

Frailty in Older Adults: Evidence for a Phenotype

Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907 · see citing works

AJCC Cancer Staging Manual

(2016) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,279 · see citing works

AJCC Cancer Staging Manual

(2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,375 · see citing works

The senescence-associated secretory phenotype: the dark side of tumor suppression

Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · see citing works

Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders

Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · see citing works

Cancer treatment and survivorship statistics, 2012

Siegel, R. L., Desantis, C. E., Virgo, K. S., Stein, K., Mariotto, A. B., Smith, T. G., Cooper, D. L., Gansler, T. S., Lerro, C. C., Fedewa, S. A., et al. (2012) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,924 · see citing works

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,091 · see citing works

Four faces of cellular senescence

Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,016 · cited 1× · see citing works

Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

Smith, B. D., Smith, G. L., Hurria, A., Hortobágyi, G. N., & Buchholz, T. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8983 · Cited by 1,723 · see citing works

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

Citron, M. L., Berry, D. A., Cirrincione, C., Hudis, C. A., Winer, E. P., Gradishar, W. J., Davidson, N. E., Martino, S., Livingston, R. B., Ingle, J. N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.081 · Cited by 1,564 · see citing works

Ink4a/Arf expression is a biomarker of aging

Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486 · see citing works

Obesity, cigarette smoking, and telomere length in women

Valdes, A., Andrew, T., Gardner, J., Kimura, M., Oelsner, E., Cherkas, L., Aviv, A., & Spector, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66630-5 · Cited by 1,363 · see citing works

Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty

Ershler, W. B., & Keller, E. T. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.245 · Cited by 1,282 · see citing works

Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age

Rossi, D. J., Bryder, D., Seita, J., Nussenzweig, A., Hoeijmakers, J., & Weissman, I. L. (2007) · Nature · doi:10.1038/nature05862 · Cited by 1,115 · see citing works

Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a

Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106 · see citing works

Cellular Senescence in Aging Primates

Herbig, U., Ferreira, M., Condel, L., Carey, D., & Sedivy, J. M. (2006) · Science · doi:10.1126/science.1122446 · Cited by 1,101 · see citing works

p16INK4a induces an age-dependent decline in islet regenerative potential

Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · see citing works

Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing

Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature05091 · Cited by 972 · see citing works

The origins of age-related proinflammatory state

Ferrucci, L., Corsi, A., Lauretani, F., Bandinelli, S., Bartali, B., Taub, D. D., Guralnik, J. M., & Longo, D. L. (2005) · Blood · doi:10.1182/blood-2004-07-2599 · Cited by 908 · see citing works

Inflammatory Markers and Physical Performance in Older Persons: The InCHIANTI Study

Cesari, M., Penninx, B. W. J. H., Pahor, M., Lauretani, F., Corsi, A. M., Williams, G. R., Guralnik, J. M., & Ferrucci, L. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m242 · Cited by 901 · see citing works

Inflammatory markers in population studies of aging

Singh, T., & Newman, A. B. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.11.002 · Cited by 866 · see citing works

How stem cells age and why this makes us grow old

Sharpless, N. E., & DePinho, R. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2241 · Cited by 843 · see citing works

Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway

Maggio, M. G., Guralnik, J. M., Longo, D. L., & Ferrucci, L. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.6.575 · Cited by 687 · see citing works

Untitled work

(2003) · PubMed · Cited by 608 · see citing works

Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence

Coppé, J.-P., Kauser, K., Campisi, J., & Beauséjour, C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603307200 · Cited by 604 · see citing works

Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging

Zindy, F., Quelle, D. E., Roussel, M. F., & Sherr, C. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201178 · Cited by 574 · see citing works

Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis

WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0977com · Cited by 527 · see citing works

Expression of <i>p16</i> ^<i>INK4a</i> in peripheral blood T‐cells is a biomarker of human aging

Liu, Y., Sanoff, H. K., Cho, H., Burd, C. E., Torrice, C., Ibrahim, J. G., Thomas, N. E., & Sharpless, N. E. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00489.x · Cited by 509 · see citing works

A systematic review of leukocyte telomere length and age in adults

Müezzinler, A., Zaineddin, A. K., & Brenner, H. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.01.003 · Cited by 474 · see citing works

Annual Report to the Nation on the status of cancer, 1975‐2008, featuring cancers associated with excess weight and lack of sufficient physical activity

Eheman, C. R., Henley, S. J., Ballard-Barbash, R. R., Jacobs, E. J., Schymura, M. J., Noone, A., Pan, L., Anderson, R. N., Fulton, J. E., Kohler, B., et al. (2012) · Cancer · doi:10.1002/cncr.27514 · Cited by 455 · see citing works

Cross-sectional and Prospective Relationships of Interleukin-6 and C-Reactive Protein With Physical Performance in Elderly Persons: MacArthur Studies of Successful Aging

Taaffe, D. R., Harris, T. B., Ferrucci, L., Rowe, J., & Seeman, T. E. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.12.m709 · Cited by 438 · see citing works

Monitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model

Burd, C. E., Sorrentino, J. A., Clark, K. S., Darr, D. B., Krishnamurthy, J., Deal, A. M., Bardeesy, N., Castrillon, D. H., Beach, D. H., & Sharpless, N. E. (2013) · Cell · doi:10.1016/j.cell.2012.12.010 · Cited by 419 · see citing works

Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study

Castellino, S. M., Geiger, A. M., Mertens, A. C., Leisenring, W. M., Tooze, J. A., Goodman, P., Stovall, M. A., Robison, L. L., & Hudson, M. M. (2010) · Blood · doi:10.1182/blood-2010-04-278796 · Cited by 366 · see citing works

Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells

Engelhardt, M. M., Kumar, R., Albanell, J., Pettengell, R., Han, W., & Moore, M. A. S. (1997) · Blood · doi:10.1182/blood.v90.1.182 · Cited by 297 · see citing works

Troublesome Symptoms in Cancer Survivors: Fatigue, Insomnia, Neuropathy, and Pain

Pachman, D. R., Barton, D. L., Swetz, K. M., & Loprinzi, C. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.7238 · Cited by 282 · see citing works

PDGF signalling controls age-dependent proliferation in pancreatic β-cells

Chen, H., Gu, X., Liu, Y., Wang, J., Wirt, S. E., Bottino, R., Schorle, H., Sage, J., & Kim, S. K. (2011) · Nature · doi:10.1038/nature10502 · Cited by 278 · see citing works

The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer

Mirabello, L. J., Huang, W., Wong, J. Y. Y., Chatterjee, N., Reding, D. J., Crawford, E. D., Vivo, I. D., Hayes, R. B., & Savage, S. A. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00485.x · Cited by 246 · see citing works

Review: a meta‐analysis of GWAS and age‐associated diseases

Jeck, W. R., Siebold, A. P., & Sharpless, N. E. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00871.x · Cited by 204 · see citing works

A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer

Ben‐Josef, E., Schipper, M. J., Francis, I. R., Hadley, S. W., Haken, R. K. T., Lawrence, T. S., Normolle, D. P., Simeone, D. M., Sonnenday, C. J., Abrams, R. A., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.02.051 · Cited by 187 · see citing works

Interleukin-6 and selected plasma proteins in healthy persons of different ages

Häger, K., Machein, U., Krieger, S., Platt, D., Seefried, G., & Bauer, J. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90066-3 · Cited by 172 · see citing works

Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues.

Nielsen, G. P., Stemmer-Rachamimov, A. O., Shaw, J., Roy, J. E., Koh, J., & Louis, D. N. (1999) · PubMed · Cited by 169 · see citing works

Lifestyle impacts on the aging-associated expression of biomarkers of DNA damage and telomere dysfunction in human blood

Song, Z., Von Figura, G., Liu, Y., Kraus, J. M., Torrice, C., Dillon, P., Rudolph‐Watabe, M., Ju, Z., Kestler, H. A., Sanoff, H., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00583.x · Cited by 163 · see citing works

Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia

Ness, K. K., Hudson, M. M., Pui, C., Green, D. M., Krull, K. R., Huang, T. T., Robison, L. L., & Morris, E. B. (2011) · Cancer · doi:10.1002/cncr.26337 · Cited by 151 · see citing works

Neurocognitive Function and CNS Integrity in Adult Survivors of Childhood Hodgkin Lymphoma

Krull, K. R., Sabin, N. D., Reddick, W. E., Zhu, L., Armstrong, G. T., Green, D. M., Arevalo, A. R., Krasin, M. J., Srivastava, D. K., Robison, L. L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.6841 · Cited by 117 · see citing works

Expression of p16INK4a prevents cancer and promotes aging in lymphocytes

Liu, Y., Johnson, S. M., Fedoriw, Y., Rogers, A. B., Yuan, H., Krishnamurthy, J., & Sharpless, N. E. (2011) · Blood · doi:10.1182/blood-2010-09-304402 · Cited by 114 · see citing works

Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16 ^Ink4a and Arf

Signer, R. A. J., Montecino-Rodriguez, E., Witte, O. N., & Dorshkind, K. (2008) · Genes &amp; Development · doi:10.1101/gad.1715808 · Cited by 102 · see citing works

Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation

Schröder, C. P., Wisman, G. B. A., de Jong, S., van der Graaf, W. T. A., Ruiters, M. H. J., Mulder, N. H., de Leij, L. F. M. H., van der Zee, A. G. J., & de Vries, E. G. E. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1803 · Cited by 101 · see citing works

Expression of <i>p16</i>^<i>INK4a</i> as a biomarker of T‐cell aging in HIV‐infected patients prior to and during antiretroviral therapy

Nelson, J. A. E., Krishnamurthy, J., Menezes, P., Liu, Y., Hudgens, M. G., Sharpless, N. E., & Eron, J. J. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00856.x · Cited by 66 · see citing works

Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: A childhood cancer survivor study report

Chow, E. J., Liu, W., Srivastava, K., Leisenring, W. M., Hayashi, R. J., Sklar, C. A., Stovall, M., Robison, L. L., & Baker, K. S. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24198 · Cited by 65 · see citing works

Fibroblast growth factor-7 partially reverses murine thymocyte progenitor aging by repression of Ink4a

Berent-Maoz, B., Montecino-Rodriguez, E., Signer, R. A. J., & Dorshkind, K. (2012) · Blood · doi:10.1182/blood-2011-12-400002 · Cited by 46 · see citing works

Granulocyte colony‐stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy

Szyper‐Kravitz, M., Uziel, O., Shapiro, H., Radnay, J., Katz, T., Rowe, J. M., Lishner, M., & Lahav, M. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04043.x · Cited by 32 · see citing works

Telomere Dynamics in Aging: Much Ado About Nothing?

Longo, D. L. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp071 · Cited by 7 · see citing works

Senescence in Health and Disease

He, S., & Sharpless, N. E. (2017) · Cell · doi:10.1016/j.cell.2017.05.015 · Cited by 1,766 · see citing works

Cellular senescence promotes adverse effects of chemotherapy and cancer relapse

Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338 · see citing works

Forging a signature of in vivo senescence

Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · see citing works

How the ageing microenvironment influences tumour progression

Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849 · see citing works

Senescence and cancer — role and therapeutic opportunities

Schmitt, C. A., Wang, B., & Demaria, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00668-4 · Cited by 794 · see citing works

Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy

Zafar, A., Khatoon, S., Khan, M. J., Abu, J., & Naeem, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-02198-8 · Cited by 601 · see citing works

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21258 · Cited by 546 · see citing works

Senescent Cells in Cancer Therapy: Friends or Foes?

Wang, B., Kohli, J., & Demaria, M. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.05.004 · Cited by 508 · see citing works

Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis

Masaldan, S., Clatworthy, S. A. S., Gamell, C., Meggyesy, P. M., Rigopoulos, A.-T., Haupt, S., Haupt, Y., Denoyer, D., Adlard, P. A., Bush, A. I., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2017.08.015 · Cited by 452 · see citing works

Mechanisms and Regulation of Cellular Senescence

Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395 · see citing works

DNA damage-how and why we age?

Yousefzadeh, M., Henpita, C., Vyas, R., Soto-Palma, C., Robbins, P., & Niedernhofer, L. (2021) · eLife · doi:10.7554/elife.62852 · Cited by 399 · see citing works

Cancer progression and the invisible phase of metastatic colonization

Klein, C. A. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00300-6 · Cited by 379 · see citing works

Cognitive Effects of Cancer and Cancer Treatments

Ahles, T. A., & Root, J. C. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084903 · Cited by 373 · see citing works

Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy

Prasanna, P. G. S., Citrin, D. E., Hildesheim, J., Ahmed, M. M., Venkatachalam, S., Riscuta, G., Xi, D., Zheng, G., van Deursen, J., Goronzy, J. J., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab064 · Cited by 351 · see citing works

Exercise therapy and cardiovascular toxicity in cancer

Scott, J. M., Nilsen, T. S., Gupta, D., & Jones, L. W. (2018) · Circulation · doi:10.1161/circulationaha.117.024671 · Cited by 239 · see citing works

Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors

Guida, J. L., Ahles, T. A., Belsky, D., Campisi, J., Cohen, H. J., DeGregori, J., Fuldner, R., Ferrucci, L., Gallicchio, L., Gavrilov, L., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz136 · Cited by 216 · see citing works

THE ROLE OF NEURO-IMMUNE INTERACTIONS IN CANCER-RELATED FATIGUE: BIOBEHAVIORAL RISK FACTORS AND MECHANISMS

Bower, J. (2019) · Cancer · doi:10.1002/cncr.31790 · Cited by 190 · see citing works

Cellular senescence in cancer: from mechanisms to detection

Ou, H., Hoffmann, R. J., González‐López, C., Doherty, G. J., Korkola, J. E., & Muñoz‐Espín, D. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12807 · Cited by 198 · see citing works

Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study

Mandelblatt, J. S., Small, B. J., Luta, G., Hurria, A., Jim, H., McDonald, B. C., Graham, D. M. A., Zhou, X., Clapp, J. D., Zhai, W., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00140 · Cited by 188 · see citing works

Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors

Kesler, S. R., & Blayney, D. W. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.4333 · Cited by 172 · see citing works

Senescent T cells: a potential biomarker and target for cancer therapy

Zhang, J., He, T., Xue, L., & Guo, H. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103409 · Cited by 171 · see citing works

Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging

Muñoz, D. P., Yannone, S. M., Daemen, A., Sun, Y., Vakar-Lopez, F., Kawahara, M., Freund, A. M., Rodier, F., Wu, J. D., Desprez, P.-Y., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124716 · Cited by 162 · see citing works

The role of epigenetic modifications in drug resistance and treatment of breast cancer

Fath, M. K., Azargoonjahromi, A., Kiani, A., Jalalifar, F., Osati, P., Oryani, M. A., Shakeri, F., Nasirzadeh, F., Khalesi, B., Nabi‐Afjadi, M., et al. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00344-6 · Cited by 151 · see citing works

Senescence and the tumor-immune landscape: Implications for cancer immunotherapy

Chibaya, L., Snyder, J. T., & Ruscetti, M. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.005 · Cited by 138 · see citing works

Disease drivers of aging

Hodes, R. J., Sierra, F., Austad, S. N., Epel, E., Neigh, G. N., Erlandson, K. M., Schafer, M. J., LeBrasseur, N. K., Wiley, C., Campisi, J., et al. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13299 · Cited by 132 · see citing works

Cancer Treatment as an Accelerated Aging Process: Assessment, Biomarkers, and Interventions

Hurria, A., Jones, L. W., & Muss, H. B. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_156160 · Cited by 133 · see citing works

Frailty and aging in cancer survivors

Ness, K. K., & Wogksch, M. D. (2020) · Translational Research · doi:10.1016/j.trsl.2020.03.013 · Cited by 124 · see citing works

Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial

Farr, J. N., Atkinson, E. J., Achenbach, S. J., Volkman, T. L., Tweed, A. J., Vos, S. J., Ruan, M., Sfeir, J., Drake, M. T., Saul, D., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03096-2 · Cited by 127 · see citing works

Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus

Bagnall-Moreau, C., Chaudhry, S., Salas-Ramirez, K. Y., Ahles, T. A., & Hubbard, K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1589-z · Cited by 118 · see citing works

Cancer Treatment-Induced Accelerated Aging in Cancer Survivors: Biology and Assessment

Wang, S., Prizment, A. E., Thyagarajan, B., & Blaes, A. H. (2021) · Cancers · doi:10.3390/cancers13030427 · Cited by 116 · see citing works

Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment

Maggiorani, D., Lê, O., Lisi, V., Landais, S., Moquin‐Beaudry, G., Lavallée, V., Decaluwe, H., & Beausejour, C. M. (2024) · Nature Communications · doi:10.1038/s41467-024-46769-9 · Cited by 123 · see citing works

New Challenges in Psycho‐Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions

Ahles, T. A., & Hurria, A. (2017) · Psycho-Oncology · doi:10.1002/pon.4564 · Cited by 107 · see citing works

Frameworks for proof-of-concept clinical trials of interventions that target fundamental aging processes

Justice, J., Miller, J. D., Newman, J. C., Hashmi, S. K., Halter, J., Austad, S. N., Barzilai, N., & Kirkland, J. L. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw126 · Cited by 96 · see citing works

Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice

Nyrop, K. A., Deal, A. M., Reeder‐Hayes, K. E., Shachar, S. S., Reeve, B. B., Basch, E., Choi, S. K., Lee, J. T., Wood, W. A., Anders, C. K., et al. (2019) · Cancer · doi:10.1002/cncr.32175 · Cited by 94 · see citing works

The G-quadruplex DNA stabilizing drug pyridostatin promotes DNA damage and downregulates transcription of Brca1 in neurons

Moruno-Manchon, J. F., Koellhoffer, E. C., Gopakumar, J., Hambarde, S., Kim, N., McCullough, L. D., & Tsvetkov, A. S. (2017) · Aging · doi:10.18632/aging.101282 · Cited by 90 · see citing works

Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer

Kesler, S. R., Watson, C., & Blayney, D. W. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.015 · Cited by 90 · see citing works

Immunotherapy in Older Adults With Advanced Cancers: Implications for Clinical Decision-Making and Future Research

Kanesvaran, R., Córdoba, R., & Maggiore, R. J. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_201435 · Cited by 91 · see citing works

Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways

Salas-Ramirez, K. Y., Bagnall, C., Frias, L., Abdali, S. A., Ahles, T. A., & Hubbard, K. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.06.028 · Cited by 88 · see citing works

Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study

Mandelblatt, J. S., Zhai, W., Ahn, J., Small, B. J., Ahles, T. A., Carroll, J., Denduluri, N., Dilawari, A. A., Extermann, M., Graham, D. M. A., et al. (2019) · Cancer · doi:10.1002/cncr.32663 · Cited by 84 · see citing works

Breast cancer treatment and its effects on aging

Chang, L., Weiner, L. S., Hartman, S. J., Horvath, S., Jeste, D. V., Mischel, P. S., & Kado, D. M. (2018) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2018.07.010 · Cited by 81 · see citing works

Accelerated aging among childhood, adolescent, and young adult cancer survivors is evidenced by increased expression of p16^INK4a and frailty

Smitherman, A. B., Wood, W. A., Mitin, N., Ayer Miller, V. L., Deal, A. M., Davis, I. J., Blatt, J., Gold, S. H., & Muss, H. B. (2020) · Cancer · doi:10.1002/cncr.33112 · Cited by 80 · see citing works

Cancer-related accelerated ageing and biobehavioural modifiers: a framework for research and clinical care

Carroll, J., Bower, J. E., & Ganz, P. A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00580-3 · Cited by 79 · see citing works

The acute effects of adjuvant radiation and chemotherapy on peripheral blood epigenetic age in early stage breast cancer patients

Sehl, M. E., Carroll, J., Horvath, S., & Bower, J. E. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-0161-3 · Cited by 77 · see citing works

Telomere Length and Breast Cancer Prognosis: A Systematic Review

Ennour‐Idrissi, K., Maunsell, E., & Diorio, C. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0343 · Cited by 75 · see citing works

Cognitive Performance in Breast Cancer Survivors and Markers of Biological Aging

Carroll, J., Dyk, K. V. V., Bower, J., Scuric, Z., Petersen, L., Schiestl, R., Irwin, M. R., & Ganz, P. (2018) · Cancer · doi:10.1002/cncr.31777 · Cited by 61 · see citing works

The senescence journey in cancer immunoediting

Zingoni, A., Antonangeli, F., Sozzani, S., Santoni, A., Cippitelli, M., & Soriani, A. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01973-5 · Cited by 74 · see citing works

p16 a biomarker of aging and tolerance for cancer therapy

Muss, H. B., Smitherman, A. B., Wood, W. A., Nyrop, K. A., Tuchman, S. A., Randhawa, P. K., Entwistle, A., Mitin, N., & Shachar, S. S. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.39 · Cited by 68 · see citing works

Comprehensive geriatric assessment in the older cancer patient: coming of age in clinical cancer care

Owusu, C., & Berger, N. A. (2014) · Clinical Practice · doi:10.2217/cpr.14.72 · Cited by 70 · see citing works

Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model

Wu, Y., Deng, Z., Wang, H., Ma, W., Zhou, C., & Zhang, S. (2016) · BMC Immunology · doi:10.1186/s12865-016-0167-7 · Cited by 69 · see citing works

Chemotherapy and Stem Cell Transplantation Increase p16 INK4a Expression, a Biomarker of T-cell Aging

Wood, W. A., Krishnamurthy, J., Mitin, N., Torrice, C., Parker, J. S., Snavely, A. C., Shea, T. C., Serody, J. S., & Sharpless, N. E. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.029 · Cited by 69 · see citing works

Defining the toxicology of aging

Sorrentino, J. A., Sanoff, H. K., & Sharpless, N. E. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.04.004 · Cited by 67 · see citing works

Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies?

Turner, J. E., & Brum, P. C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4234765 · Cited by 65 · see citing works

Biomarkers of aging associated with past treatments in breast cancer survivors

Scuric, Z., Carroll, J., Bower, J. E., Ramos-Perlberg, S., Petersen, L., Esquivel, S., Hogan, M., Chapman, A. M., Irwin, M. R., Breen, E. C., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0050-6 · Cited by 61 · see citing works

Cognitive Function in Older Adults With Cancer: Assessment, Management, and Research Opportunities

Magnuson, A. M., Ahles, T. A., Chen, B. T., Mandelblatt, J. S., & Janelsins, M. C. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00239 · Cited by 62 · see citing works

Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study

Mandelblatt, J. S., Zhou, X., Small, B. J., Ahn, J., Zhai, W., Ahles, T. A., Extermann, M., Graham, D. M. A., Jacobsen, P. B., Jim, H., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab003 · Cited by 57 · see citing works

A New Approach to Understanding Cancer-Related Fatigue: Leveraging the 3P Model to Facilitate Risk Prediction and Clinical Care

Sleight, A. G., Crowder, S. L., Skarbinski, J., Coen, P. M., Parker, N. H., Hoogland, A. I., Gonzalez, B. D., Playdon, M. C., Cole, S. W., Ose, J., et al. (2022) · Cancers · doi:10.3390/cancers14081982 · Cited by 59 · see citing works

TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin

Moruno-Manchon, J. F., Uzor, N.-E., Kesler, S. R., Wefel, J. S., Townley, D. M., Nagaraja, A. S., Pradeep, S., Mangala, L. S., Sood, A. K., & Tsvetkov, A. S. (2016) · Aging · doi:10.18632/aging.101144 · Cited by 58 · see citing works

Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies

Chakrabarty, A., Chakraborty, S., Bhattacharya, R., & Chowdhury, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.674354 · Cited by 56 · see citing works

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters

Brouwers, B. A. H., Hatse, S., Lago, L. D., Neven, P., Vuylsteke, P., Dalmasso, B., Debrock, G., den Bulck, H. V., Smeets, A., Bechter, O. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8796 · Cited by 55 · see citing works

Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes

Xiong, J., Dong, L., Lv, Q., Yin, Y., Zhao, J., Ke, Y., Wang, S., Zhang, W., & Wu, M. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1772 · Cited by 55 · see citing works

Restored immune cell functions upon clearance of senescence in the irradiated splenic environment

Palacio, L., Goyer, M., Maggiorani, D., Espinosa, A., Villeneuve, N., Bourbonnais, S., Moquin‐Beaudry, G., Le, O., Demaria, M., Davalos, A. R., et al. (2019) · Aging Cell · doi:10.1111/acel.12971 · Cited by 54 · see citing works

Applying a Life Course Biological Age Framework to Improving the Care of Individuals With Adult Cancers

Mandelblatt, J. S., Ahles, T. A., Lippman, M. E., Isaacs, C. J., Adams-Campbell, L. L., Saykin, A. J., Cohen, H. J., & Carroll, J. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1160 · Cited by 53 · see citing works

Cellular senescence and other age-related mechanisms in skeletal diseases

Li, K., Hu, S., & Chen, H. (2025) · Bone Research · doi:10.1038/s41413-025-00448-7 · Cited by 58 · see citing works

The 2014–2018 Oncology Nursing Society Research Agenda

Knobf, M. T., Cooley, M. E., Duffy, S. A., Doorenbos, A. Z., Eaton, L. H., Given, B. A., Mayer, D. K., McCorkle, R. C., Miaskowski, C. A., Mitchell, S. A., et al. (2015) · Oncology nursing forum · doi:10.1188/15.onf.450-465 · Cited by 55 · see citing works

Assessment of cell cycle regulators in human peripheral blood cells as markers of cellular senescence

Guan, L., Crasta, K., & Maier, A. B. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101634 · Cited by 53 · see citing works

The Independent Effects of Strength Training in Cancer Survivors: a Systematic Review

Hanson, E. D., Wagoner, C. W., Anderson, T., & Battaglini, C. L. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0511-3 · Cited by 52 · see citing works

Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy

Moruno-Manchon, J. F., Uzor, N.-E., Kesler, S. R., Wefel, J. S., Townley, D. M., Nagaraja, A. S., Pradeep, S., Mangala, L. S., Sood, A. K., & Tsvetkov, A. S. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.11.014 · Cited by 52 · see citing works

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial

Knight, J. M., Rizzo, J. D., Hari, P., Pasquini, M. C., Giles, K. E., D’Souza, A., Logan, B. R., Hamadani, M., Chhabra, S., Dhakal, B., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000765 · Cited by 53 · see citing works

A chimeric peptide promotes immune surveillance of senescent cells in injury, fibrosis, tumorigenesis and aging

Ming, X., Yang, Z. R., Huang, Y., Wang, Z., Zhang, Q., Lu, C., Sun, Y., Chen, Y., Zhang, L., Wu, J., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00750-9 · Cited by 54 · see citing works

The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature

Gallicchio, L. M., Gadalla, S. M., Murphy, J. D., & Simonds, N. I. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy189 · Cited by 51 · see citing works

The senescence-associated secretory phenotype: Fueling a wound that never heals

Pulido, T., Velarde, M. C., & Alimirah, F. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111561 · Cited by 52 · see citing works

Management of Cancer in the Older Age Person: An Approach to Complex Medical Decisions

Vallet‐Regí, M., Manzano, M., Rodríguez‐Mañas, L., Checa‐López, M., Aapro, M., & Balducci, L. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0276 · Cited by 50 · see citing works

Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments

Yoo, K. H., Tang, J. J., Rashid, M. A., Cho, C. H., Corujo-Ramirez, A. M., Choi, J., Bae, M. G., Brogren, D., Hawse, J. R., Hou, X., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3290 · Cited by 49 · see citing works

Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics

Kato, S., Schwaederle, M. C., Daniels, G. A., Piccioni, D. E., Kesari, S., Bazhenova, L. A., Shimabukuro, K. A., Parker, B. A., Fanta, P. T., & Kurzrock, R. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1014149 · Cited by 49 · see citing works

The prevalence of frailty among breast cancer patients: a systematic review and meta-analysis

Wang, S., Yang, T., Qiang, W., Shen, A., Zhao, Z., Yang, H., & Liu, X. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06641-8 · Cited by 50 · see citing works

Probability of Alzheimer's disease in breast cancer survivors based on gray‐matter structural network efficiency

Kesler, S. R., Rao, V., Ray, W. J., Rao, A. U. K., & Initiative, A. D. N. (2017) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.10.002 · Cited by 48 · see citing works

Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence

Abdelgawad, I. Y., Sadak, K. T., Lone, D. W., Dabour, M. S., Niedernhofer, L. J., & Zordoky, B. N. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107751 · Cited by 47 · see citing works

Mouse Models of Accelerated Cellular Senescence

Yousefzadeh, M. J., Melos, K. I., Angelini, L. A., Burd, C. E., Robbins, P. D., & Niedernhofer, L. J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_17 · Cited by 47 · see citing works

Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study

Rentscher, K. E., Bethea, T. N., Zhai, W., Small, B. J., Zhou, X., Ahles, T. A., Ahn, J., Breen, E. C., Cohen, H. J., Extermann, M., et al. (2023) · Cancer · doi:10.1002/cncr.34818 · Cited by 47 · see citing works

Cancer and Aging

Li, D., de Glas, N. A., & Hurria, A. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.08.003 · Cited by 44 · see citing works

Aspirin ameliorates the long‐term adverse effects of doxorubicin through suppression of cellular senescence

Feng, M., Kim, J., Field, K. P., Reid, C., Chatzistamou, I., & Shim, M. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00041 · Cited by 42 · see citing works

Relationship between cognitive functioning and frailty in older breast cancer survivors

Ahles, T. A., Schofield, E., Li, Y., Ryan, E., Root, J. C., Patel, S. K., McNeal, K., Gaynor, A. M., Tan, H., Katheria, V., et al. (2021) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2021.07.011 · Cited by 43 · see citing works

Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells

Morsli, S., Doherty, G. J., & Muñoz‐Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 41 · see citing works

The Achilles’ heel of cancer survivors: fundamentals of accelerated cellular senescence

Shafqat, S., Arana‐Chicas, E., Shafqat, A., & Hashmi, S. K. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158452 · Cited by 42 · see citing works

Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma

Rosko, A. E., Hofmeister, C. C., Benson, D. M., Efebera, Y. A., Huang, Y., Gillahan, J. E., Byrd, J. C., & Burd, C. E. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.143 · Cited by 40 · see citing works

Optimal management of breast cancer in the elderly patient: current perspectives

Falandry, C., Saux, O. L., Freyer, G., Bonnefoy, M., Ripamonti, B., Bonin, O., & Bruyas, A. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s50670 · Cited by 40 · see citing works

Do Cancer and Cancer Treatments Accelerate Aging?

Bhatia, R., Holtan, S. G., Jurdi, N. E., Prizment, A. E., & Blaes, A. H. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01311-2 · Cited by 39 · see citing works

Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer

Pardella, E., Pranzini, E., Nesi, I., Parri, M., Spatafora, P., Torre, E., Muccilli, A., Castiglione, F., Fambrini, M., Sorbi, F., et al. (2022) · Cells · doi:10.3390/cells11244026 · Cited by 39 · see citing works

Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study

Onyema, O. O., Decoster, L., Njemini, R., Forti, L. N., Bautmans, I., Waele, M. D., & Mets, T. F. (2015) · BMC Cancer · doi:10.1186/s12885-015-2013-3 · Cited by 38 · see citing works

Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer

Henneghan, A. M., Rao, V., Harrison, R. A., Karuturi, M. S., Blayney, D. W., Palesh, O. G., & Kesler, S. R. (2020) · Neurotoxicity Research · doi:10.1007/s12640-019-00158-z · Cited by 37 · see citing works

Circuit resistance training and cardiovascular health in breast cancer survivors

Jones, L. M., Stoner, L. R., Baldi, J. C., & McLaren, B. R. (2020) · European Journal of Cancer Care · doi:10.1111/ecc.13231 · Cited by 37 · see citing works

Cardio-Oncology rehabilitation- challenges and opportunities to improve cardiovascular outcomes in cancer patients and survivors

Sase, K., Kida, K., & Furukawa, Y. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.07.014 · Cited by 36 · see citing works

Bone Marrow Senescence and the Microenvironment of Hematological Malignancies

Hellmich, C., Moore, J. A., Bowles, K. M., & Rushworth, S. A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00230 · Cited by 35 · see citing works

TFEB protein expression is reduced in aged brains and its overexpression mitigates senescence-associated biomarkers and memory deficits in mice

Wang, H., Karuppan, M. K. M., Devadoss, D., Nair, M., Chand, H. S., & Lakshmana, M. K. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.003 · Cited by 35 · see citing works

Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiation

Kotla, S., Zhang, A., Imanishi, M., Ko, K. A., Lin, S. H., Gi, Y. J., Moczygemba, M. M., Isgandarova, S., Schadler, K., Chung, C. D., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102132 · Cited by 36 · see citing works

Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy

Speidell, A. P., Demby, T. C., Lee, Y., Rodriguez, O. C., Albanese, C., Mandelblatt, J. S., & Rebeck, G. W. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9954-7 · Cited by 35 · see citing works

Assessing Biological Age

López-Jiménez, F. A., Kapa, S., Friedman, P. A., LeBrasseur, N. K., Klavetter, E. W., Mangold, K. E., & Attia, Z. I. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.02.011 · Cited by 36 · see citing works

Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients

Benitéz‐Buelga, C., Sánchez, L. M. M., Gallardo, M., Apellániz-Ruiz, M., Inglada‐Pérez, L., Yanowsky, K., Carrillo, J., García‐Estévez, L., Calvo, I., Perona, R., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3246-6 · Cited by 34 · see citing works

Reverse geroscience: how does exposure to early diseases accelerate the age‐related decline in health?

Kohanski, R. A., Deeks, S. G., Gravekamp, C., Halter, J. B., High, K. P., Hurria, A., Fuldner, R., Green, P. A., Huebner, R. E., Macchiarini, F., et al. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13297 · Cited by 33 · see citing works

Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer

Yuan, Y., Vora, N. L., Sun, C., Li, D., Soto‐Pérez‐de‐Celis, E., Mortimer, J. E., Luu, T. H., Somlo, G., Waisman, J. R., Smith, D. D., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0895-5 · Cited by 34 · see citing works

Chemotherapy May Hasten Aging

(2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-nb2014-059

P16INK4aexpression after chemotherapy in older women with early-stage breast cancer.

Muss, H. B., Krishnamurthy, J., Alston, S. M., Lacy, A., Jolly, T. A., Williams, G., Carey, L., Dees, E. C., Anders, C., Irvin, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.9002 · Cited by 8 · see citing works

Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16INK4a

Shachar, S. S., Deal, A. M., Reeder-Hayes, K. E., Nyrop, K. A., Mitin, N., Anders, C. K., Carey, L., Dees, E. C., Jolly, T. A., Kimmick, G. G., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa082 · Cited by 33 · see citing works

Long‐Term Follow‐Up of Chemotherapy‐Associated Biological Aging in Women With Early Breast Cancer

Muss, H. B., Wardell, A. C., Deal, A. M., Nyrop, K. A., Ross, A., Abdou, Y. G., Aldrich, J. D., Cary, L. A., Dees, E. C., Reeder-Hayes, K. E., et al. (2026) · Aging and Cancer · doi:10.1002/aac2.70022 · Cited by 1 · see citing works

Abstract P6-08-34: p16INK4a expression and chemotherapy toxicity in women with early stage breast cancer

Muss, H. B., Deal, A. M., Hurria, A., Mitin, N., Torrice, C., Krishnamurthy, J., Jolly, T. A., Williams, G., Alston, S. M., West, J., et al. (2015) · Cancer Research · doi:10.1158/1538-7445.sabcs14-p6-08-34